Background: Obesity has become a major public health challenge in recent years. Recent studies suggest that alterations of the gut microbiota by antibiotics could play an important role in obesity. Methods: We investigated this topic using 60 Wistar rats, which were divided into 3 experimental groups: rats treated with amoxicillin, rats treated with amoxicillin plus Saccharomyces boulardii and controls. Treatments were administered over the course of 2 weeks. Tetrapolar bioelectric impedance analysis and anthropometric evaluations were conducted. Results: The body mass index was significantly lower for the animals in the control group (p = 0.034). The same result was observed for the Lee index: the control group had a lower index than the 2 groups that received antibiotic treatment (p = 0.0019). The total body water data demonstrated that the control group had the greatest amount of body water (279.1 g, p = 0.0243). Conclusions: The groups treated with the antibiotic exhibited a greater accumulation of body fat than the control group.

1.
Murphy EF, Clarke SF, Marques TM, et al: Antimicrobials: strategies for targeting obesity and metabolic health? Gut Microbes 2013;4:48-53.
[PubMed]
2.
Riley LW, Raphael E, Faerstein E: Obesity in the United States - dysbiosis from exposure to low-dose antibiotics? Front Public Health 2013;1:69.
[PubMed]
3.
Newnham JP, Pennell CE, Lye SJ, Rampono J, Challis JR: Early life origins of obesity. Obstet Gynecol Clin North Am 2009;36:227-244, xii.
[PubMed]
4.
Million M, Lagier JC, Yahav D, Paul M: Gut bacterial microbiota and obesity. Clin Microbiol Infect 2013;19:305-313.
[PubMed]
5.
Maraki S, Mouzas IA, Kontoyiannis DP, Chatzinikolaou I, Tselentis Y, Samonis G: Prospective evaluation of the impact of amoxicillin, clarithromycin and their combination on human gastrointestinal colonization by Candida species. Chemotherapy 2001;47:215-218.
[PubMed]
6.
Cho I, Yamanishi S, Cox L, et al: Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 2012;488:621-626.
[PubMed]
7.
Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ: Infant antibiotic exposures and early-life body mass. Int J Obes (Lond) 2013;37:16-23.
[PubMed]
8.
Ajslev TA, Andersen CS, Gamborg M, Sorensen TI, Jess T: Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics. Int J Obes (Lond) 2011;35:522-529.
[PubMed]
9.
Libby DA, Schaible PJ: Observations on growth responses to antibiotics and arsonic acids in poultry feeds. Science 1955;121:733-734.
[PubMed]
10.
Gaskins HR, Collier CT, Anderson DB: Antibiotics as growth promotants: mode of action. Anim Biotechnol 2002;13:29-42.
[PubMed]
11.
Lin J: Antibiotic growth promoters enhance animal production by targeting intestinal bile salt hydrolase and its producers. Front Microbiol 2014;5:33.
[PubMed]
12.
Lin J, Hunkapiller AA, Layton AC, Chang YJ, Robbins KR: Response of intestinal microbiota to antibiotic growth promoters in chickens. Foodborne Pathog Dis 2013;10:331-337.
[PubMed]
13.
Reinhardt C, Reigstad CS, Backhed F: Intestinal microbiota during infancy and its implications for obesity. J Pediatr Gastroenterol Nutr 2009;48:249-256.
[PubMed]
14.
Agans R, Rigsbee L, Kenche H, Michail S, Khamis HJ, Paliy O: Distal gut microbiota of adolescent children is different from that of adults. FEMS Microbiol Ecol 2011;77:404-412.
[PubMed]
15.
Vael C, Verhulst SL, Nelen V, Goossens H, Desager KN: Intestinal microflora and body mass index during the first three years of life: an observational study. Gut Pathog 2011;3:8.
[PubMed]
16.
Markle JG, Frank DN, Mortin-Toth S, et al: Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 2013;339:1084-1088.
[PubMed]
17.
Grzeskowiak L, Collado MC, Mangani C, et al: Distinct gut microbiota in southeastern African and northern European infants. J Pediatr Gastroenterol Nutr 2012;54:812-816.
[PubMed]
18.
Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI: Host-bacterial mutualism in the human intestine. Science 2005;307:1915-1920.
[PubMed]
19.
Salminen S, Isolauri E, Onnela T: Gut flora in normal and disordered states. Chemotherapy 1995;41(suppl 1):5-15.
[PubMed]
20.
Bibiloni MD, Pons A, Tur JA: Prevalence of overweight and obesity in adolescents: a systematic review. ISRN Obes 2013;2013:392747.
[PubMed]
21.
Ternak G: Antibiotics may act as growth/obesity promoters in humans as an inadvertent result of antibiotic pollution? Med Hypotheses 2005;64:14-16.
[PubMed]
22.
Hall CB, Lukaski HC, Marchello MJ: Estimation of rat body composition using tetrapolar bioelectrical impedance analysis. Nutr Rep Int 1989;39:627-633.
23.
Yokoi K, Lukaski HC, Uthus EO, Nielsen FH: Use of bioimpedance spectroscopy to estimate body water distribution in rats fed high dietary sulfur amino acids. J Nutr 2001;131:1302-1308.
[PubMed]
24.
Novelli EL, Diniz YS, Galhardi CM, et al: Anthropometrical parameters and markers of obesity in rats. Lab Anim 2007;41:111-119.
[PubMed]
25.
Bernardis LL: Prediction of carcass fat, water and lean body mass from Lee's ‘nutritive ratio' in rats with hypothalamic obesity. Experientia 1970;26:789-790.
[PubMed]
26.
Gerbaix M, Metz L, Ringot E, Courteix D: Visceral fat mass determination in rodent: validation of dual-energy X-ray absorptiometry and anthropometric techniques in fat and lean rats. Lipids Health Dis 2010;9:140.
[PubMed]
27.
Morbach CA, Brans YW: Determination of body composition in growing rats by total body electrical conductivity. J Pediatr Gastroenterol Nutr 1992;14:283-292.
[PubMed]
28.
Lesser GT, Deutsch S, Markofsky J: Fat-free mass, total body water, and intracellular water in the aged rat. Am J Physiol 1980;238:R82-R90.
[PubMed]
29.
Morel FB, Oosting A, Piloquet H, Oozeer R, Darmaun D, Michel C: Can antibiotic treatment in preweaning rats alter body composition in adulthood? Neonatology 2013;103:182-189.
[PubMed]
30.
Sheng HP, Huggins RA: A review of body composition studies with emphasis on total body water and fat. Am J Clin Nutr 1979;32:630-647.
[PubMed]
31.
Mozes S, Sefcikova Z, Bujnakova D, Racek L: Effect of antibiotic treatment on intestinal microbial and enzymatic development in postnatally overfed obese rats. Obesity (Silver Spring) 2013;21:1635-1642.
[PubMed]
32.
Southern KW, Barker PM, Solis-Moya A, Patel L: Macrolide antibiotics for cystic fibrosis. Cochrane Database Syst Rev 2012;11:CD002203.
[PubMed]
33.
Garly ML, Bale C, Martins CL, et al: Prophylactic antibiotics to prevent pneumonia and other complications after measles: community based randomised double blind placebo controlled trial in Guinea-Bissau. BMJ 2006;333:1245.
[PubMed]
34.
Dibner JJ, Richards JD: Antibiotic growth promoters in agriculture: history and mode of action. Poult Sci 2005;84:634-643.
[PubMed]
35.
Koluman A, Dikici A: Antimicrobial resistance of emerging foodborne pathogens: status quo and global trends. Crit Rev Microbiol 2013;39:57-69.
[PubMed]
36.
Moore PR, Evenson A, et al: Use of sulfasuxidine, streptothricin, and streptomycin in nutritional studies with the chick. J Biol Chem 1946;165:437-441.
[PubMed]
37.
Shan LS, Hou P, Wang ZJ, et al: Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections. Benef Microbes 2013;4:329-334.
[PubMed]
38.
Szajewska H, Mrukowicz J: Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2005;22:365-372.
[PubMed]
39.
Kotowska M, Albrecht P, Szajewska H: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2005;21:583-590.
[PubMed]
40.
Million M, Angelakis E, Paul M, Armougom F, Leibovici L, Raoult D: Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb Pathog 2012;53:100-108.
[PubMed]
41.
Angelakis E, Merhej V, Raoult D: Related actions of probiotics and antibiotics on gut microbiota and weight modification. Lancet Infect Dis 2013;13:889-899.
[PubMed]
42.
Le Luyer B, Makhoul G, Duhamel JF: A multicentric study of a lactose free formula supplemented with Saccharomyces boulardii in children with acute diarrhea (in French). Arch Pediatr 2010;17:459-465.
[PubMed]
43.
Yin YN, Yu QF, Fu N, Liu XW, Lu FG: Effects of four Bifidobacteria on obesity in high-fat diet induced rats. World J Gastroenterol 2010;16:3394-3401.
[PubMed]
44.
Thuny F, Richet H, Casalta JP, Angelakis E, Habib G, Raoult D: Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PLoS One 2010;5:e9074.
[PubMed]
45.
Pirzada OM, McGaw J, Taylor CJ, Everard ML: Improved lung function and body mass index associated with long-term use of macrolide antibiotics. J Cyst Fibros 2003;2:69-71.
[PubMed]
46.
Saiman L, Anstead M, Mayer-Hamblett N, et al: Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 2010;303:1707-1715.
[PubMed]
47.
Ng YY, Su PH, Chen JY, et al: Efficacy of intermediate-dose oral erythromycin on very low birth weight infants with feeding intolerance. Pediatr Neonatol 2012;53:34-40.
[PubMed]
48.
Lane JA, Murray LJ, Harvey IM, Donovan JL, Nair P, Harvey RF: Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment Pharmacol Ther 2011;33:922-929.
[PubMed]
49.
Backhed F, Ding H, Wang T, et al: The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004;101:15718-15723.
[PubMed]
50.
Turnbaugh PJ, Backhed F, Fulton L, Gordon JI: Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008;3:213-223.
[PubMed]
You do not currently have access to this content.